Search results for: Determining Value
Filter search results
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…the value of individual indications (or patient sub-groups) for which a product is authorised. MIP can increase both static and dynamic efficiency: prices will be set at a cost-effective level,…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…affect smaller patient populations. NMEs generate different amounts of health value This may seem intuitive, but drugs generate different amounts of value. The total value a drug delivers depends on…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…Mestre‐Ferrandiz, J., 2015. Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context. Health Economics, 24(3), pp.294–301. https://doi.org/10.1002/hec.3021. Chalkidou, K., Claxton, K., Silverman, R. and Yadav, P., 2020. Value-based…
End of Life Treatments, Societal Values, and ‘Overall’ Preference
12 February 2019
OHE’s Koonal Shah gave a presentation on societal values and the provision of end of life treatments at a Manchester Centre for Health Economics seminar. On 4th February, OHE’s Koonal…
The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback
5 March 2019
…that MIC purchasers are willing to pay a value premium for innovation—potentially far higher than the cost of less effective generic competitors, but low enough to ensure local value and…
OHE at the EuroQol Plenary Meeting 2017
26 September 2017
…paper proposes a framework in which the factor of ‘experience’ is detached from other factors, such as what is being valued, whose health state is being valued, and when the…
OHE Lunchtime Seminar: Economic Evaluation for Decision-Making and the Value of Access to Individual Patient Data
13 February 2017, 12:00am
…those tasked with providing information to support policy making. This lecture will offer a health economics perspective on the value of access to individual patient-level data (IPD) to guide HTA-like…
The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence
20 June 2022, 11:00pm
…economics. The Value of a QALY towards the End of Life and its Determinants: Experimental Evidence OBJECTIVE End-of-life healthcare expenditure (HCE) is a substantial contributor to overall HCE. A widely…
Economics of Innovation
…the value of treatment alternatives to mitigate this issue. 10 June 2025 Taking STRIDES: The value of diagnostics against AMR Addressing a critical gap in AMR policy and evaluation Antimicrobial…